Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPS6360998B2 - - Google Patents
[go: Go Back, main page]

JPS6360998B2 - - Google Patents

Info

Publication number
JPS6360998B2
JPS6360998B2 JP9812582A JP9812582A JPS6360998B2 JP S6360998 B2 JPS6360998 B2 JP S6360998B2 JP 9812582 A JP9812582 A JP 9812582A JP 9812582 A JP9812582 A JP 9812582A JP S6360998 B2 JPS6360998 B2 JP S6360998B2
Authority
JP
Japan
Prior art keywords
trehalose
enzyme
maltose
phosphorylase
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP9812582A
Other languages
Japanese (ja)
Other versions
JPS58216695A (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP9812582A priority Critical patent/JPS58216695A/en
Publication of JPS58216695A publication Critical patent/JPS58216695A/en
Publication of JPS6360998B2 publication Critical patent/JPS6360998B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Description

【発明の詳細な説明】 本発明は、トレハロースの新規な製造方法に関
する。 トレハロースは、別名ミコースとも呼ばれ酵
母、カビ、海藻等の天然物中に広く分布する二糖
類である。これは他の二糖類例えばシユークロー
ス等に比し極めて安定なところから甘味剤、増量
剤等として又エネルギー源として広く利用されて
いる。従来この物質を得る方法としては、上記天
然物から抽出する方法又はアースロバクター
(Arthrobacter)属に属する微生物〔Agric.Biol。
Chem.、33、No.2、190、1969、Suzuki T、
Tanaka K & Kinoshita S〕やノカルデイ
ア(Nocardia)属に属する微生物〔特開昭50−
154485〕等の微生物の醗酵による方法が知られる
が、これらの方法は、大量生産が困難であるか又
は食品として安全に利用できるまで精製して収得
するには操作的、設備的及びエネルギー的に多大
の投資が必要であり、現在該トレハロースを安価
にしかも大量に供給する技術は確立されていな
い。 本発明者等は、上記従来法の欠点をすべて解消
し、安価にしかも高収率で大量に該トレハロース
を収得できる新規な方法を提供することを目的と
して鋭意研究を重ねた。その結果、安価に且つ大
量に入手できるマルトースを原料として、これに
マルトースホスホリラーゼ及びトレハロースホス
ホリラーゼを組み合せ作用させる時には、容易に
且つ高収率でトレハロースを製造できることを見
い出した。 本発明はこの新しい知見に基づいて完成された
ものである。 即ち本発明はマルトースをマルトースホスホリ
ラーゼ及びトレハロースホスホリラーゼで処理し
てトレハロースを製造することを特徴とするトレ
ハロースの製造法に係る。 本発明方法によれば上記異なる二種の酵素を組
み合せ使用することに基づいて、原料とするマル
トースから高収率でしかも容易に且つ効率よくト
レハロースを収得することができる。本発明方法
による上記マルトースからトレハロースへの転換
率(即ち収率)は、実に約60%前後に及ぶもので
あり、これは上記各酵素につき知られている性質
からは全く予期できないものである。 本発明における原料マルトースのマルトースホ
スホリラーゼ及びトレハロースホスホリラーゼの
組み合せによる酵素処理は、通常りん酸の存在下
に、適当な溶媒中で行なわれる。ここで用いられ
る各酵素としては、公知の市販品又は之等酵素を
生産する微生物の培養により得られるもののいず
れでもよい。特にマルトースホスホリラーゼとし
ては例えばネイセリア メニンギデイス
(Neisseria meningitidis)や(J.Biol.Chem.、
199、153〜163(1952)参照(やラクトバチルス
ブレビス(Lactobacillus brevis)等の生産する
酵素が好ましい。またトレハロースホスホリラー
ゼとしてはユーグレナ グラチリス(Euglena
gracilis)(J.Biol.Chem.、247、3223〜3228
(1972)参照)等の生産するそれが好ましい。之
等各酵素の併用量は特に制限されず、適宜に決定
される。通常原料とするマルトース1モルに対し
てマルトースホスホリラーゼは、0.1単位以上、
好ましくは約350単位以上、またトレハロースホ
スホリラーゼは0.05単位以上、好ましくは約200
単位以上とされるのがよい。之等各酵素量を表わ
す単位は、後記する方法により規定されるもので
ある。 また酵素処理系に存在させるりん酸としては、
オルトりん酸の他りん酸ナトリウム、りん酸カリ
ウム、りん酸二水素ナトリウム、りん酸二水素カ
リウム等の通常の無機りん酸及びその塩等の各種
のものを使用できる。之等のうちではりん酸二水
素カリウムが好ましい。上記りん酸はまた通常好
ましくはりん酸塩緩衝液液の形態で用いられる。
従つて上記酵素処理系を構成する溶媒は、通常上
記緩液を構成する水とされる。更に上記酵素処理
系には、酵素反応に悪影響を与えない各種の溶媒
例えば好ましくはイミダゾール−塩酸溶液等を添
加することができる。上記りん酸の使用割合(濃
度)は、特に限定的ではないが、通常原料とする
マルトース1モルに対して約0.1モル以上、好ま
しくは約0.5〜1.5モルのりん酸(又はその塩)が
存在する量(濃度)とされるのがよい。酵素反応
は通常約20〜50℃、好ましくは約37℃付近の温度
下に約24時間前後で完了する。また上記酵素処理
反応系のPHは、用いる各酵素がいずれも失活しな
い範囲、通常好ましくは約5〜8、より好ましく
は約6〜7の範囲とされる。 上記本発明の酵素処理反応終了後、反応液はこ
れを加熱して酵素を失活させ、次いで遠心分離、
過等の通常の手段により沈殿物を除去し、得ら
れる上清を例えばドウエツクス−1(Dowex−
1)、ダウケミカル社製)、CM−セルロース
(CM−cellulose)等のアニオン型イオン交換樹
脂で処理することにより糖液として精製すること
ができ、かくして得られる混合液は、これを更に
ホウ酸型陰イオン交換樹脂に吸着させ、次いで10
mM程度のホウ酸カリウム水溶液で溶出させるこ
とにより、はじめにトレハロースが溶出し、該ト
レハロースの溶出終了後に未反応マルトース及び
副生するグルコースが順次溶出する。上記により
溶出されるトレハロース画分はこれをカチオン型
イオン交換樹脂に通過させ、通過液をアンモニア
で中性付近までもどし、濃縮後、メタノール、エ
タノール等の低級アルコールを加えて蒸留してホ
ウ酸分を除去することにより、柱状のトレハロー
ス結晶を得ることができる。 本発明方法はまた上記二種の酵素を夫々別個に
又は予め上記適当割合となるように混合後、公知
の固定化手段例えばゲル包括法、マイクロカプセ
ル法等に従い固定化し、得られる固定化酵素
(夫々別個に固定化した場合は得られる各固定化
酵素を適当割合に混合する)を用いて連続的に実
施することもできる。この固定化酵素を用いる連
続的方法によれば、反応系に不純物の混入が非常
に少なくなり、より一層高純度のトレハロースを
容易に収得できるのみならず、用いる固定化酵素
は反復使用でき、上記トレハロースの製造がより
一層効率よく実施できる利点がある。上記固定化
酵素を用いる方法は、これを適当なカラムに充填
し、これに例えばりん酸緩衝液に溶解した原料マ
ルトースを通過させることにより行なわれ、通過
液(酵素処理された液)は、上記と同様にイオン
交換樹脂を用いて精製処理される。 かくして本発明によれば、安価に且つ大量にし
かも高収率でトレハロースを収得できる。 以下本発明を更に詳しく説明するため実施例を
挙げる。尚各実施例に用いた各酵素は、以下の方
法により調整したものである。 マルトースホスホリラーゼの調製 ラクトバチルス ブレビス(Lactobacillus
brevis)IFO3345の培養菌体87gをガラスビー
ズ(直径0.1〜0.2mm)を用いてセルミルで破砕
後、遠心分離して上清535ml(酵素活性2600単
位)を回収した。次にこの上清515mlに、2%
プロタミン硫酸80ml硫酸を加え、12℃で30分間
撹拌後、遠心分離し、上清580ml(酵素活性
2395単位)を回収した。これに硫酸アンモニウ
ム140gを加え(40%飽和)、2℃で30分間撹拌
したのち、遠心分離して沈殿を除去し、さらに
硫酸アンモニウム170gを加え(80%飽和)、2
℃で12時間放置し、生じた沈殿を遠心分離にて
取得した。沈殿を100mlの5mMクエン酸緩衝
液(PH6.6)に溶解し、大量の同緩衝液で2℃
冷却下に20時間透析を行つた。これを5mMク
エン酸緩衝液(PH6.6)で平衡化させたDEAE
−セルロースカラム(直径4×27cm)に通し、
吸着させた。5mMクエン酸緩衝液(PH6.6)
で洗つた後、0〜1M NaCl(クエン酸緩衝液、
PH6.6)のリニアーグラデイエントで蛋白を溶
出させた。20mlずつの分画を行ない、活性画分
を集めて、再び5mMクエン酸緩衝液(PH6.6)
に対し20時間の透析を行ない、同様にDEAE−
セルロースによるカラムクロマトグラフイーを
行つた。この操作で得られた酵素溶液に80%飽
和となるよう硫酸アンモニウムを加え、4℃で
一晩放置した。沈殿は遠心分離により集め、5
mMクエン酸緩衝液(PH6.6)に溶解し、粗酵
素標品20mlを得た。酵素活性は1638単位であつ
た。 上記マルトースホスホリラーゼにおける単位
は、以下により求められたものである。即ち
0.2モル濃度のK2HPO4−クエン酸緩衝液(PH
5.2)の0.mlに酵素溶液0.6mlを加え37℃中に5
分間置いて予熱する。この時対照として酵素液
のかわりに水を用いたものを同時に用意し、以
下同様に行う。次に0.2mlの0.2M濃度のマルト
ースを加え、37℃にて10分間反応させる。次に
沸騰した湯浴中に浸して反応を停止させる。次
にこの反応液中に生じたグルコースの量をグル
コースオキシダーゼ法により定量する。この条
件下で1分間に1μモル(180μg)のグルコー
スを生成する酵素量を1単位とした。 トレハロースホスホリラーゼの調製 ユーグレナ グラチリス(Euglena
gracilisvar.bacillaris)の培養菌体500g(湿
潤重量)を2mM−EDTA−4mM−りん酸
カリウム緩衝液(PH7.0)−25%グリセロール
600mlに懸濁した。これを200mlずつ氷水中で冷
却しながら超音波処理し菌体を破砕し、
8000rpmの遠心分離により上清を得、更に沈殿
を洗浄し、上記上清と洗浄液とを合せ粗酵素抽
出液1610mlを得た。この液をプロタミン処理
し、沈殿した酵素を集め、上記と同一の緩衝液
に再懸濁させ粗酵素標品300mlを得た。その酵
素活性は86単位であつた。 上記トレハロースホスホリラーゼにおける単
位は、以下により求められたものである。即ち
20mlに基質液(100mMイミダゾール−HCl緩
衝液(PH7.0)、100mlMりん酸緩衝液(PH7.0)、
100mMトレハロース)に20μの酵素液を加
え、37℃にて10分間反応させた後、0.5mlのソ
モジ(Somogi)試薬を加え沸騰する湯浴中で
15分間加熱する。次に冷却後ネルソン
(Nelson)試薬0.5mlを加え室温で20分間放置
する。次に水を4ml加えて、500nmで比色し、
反応系に生じたグルコースの量を求める。この
条件下で1時間に1μモルのグルコースを生成
する酵素量を1単位とした。 実施例 1 下記組成の混合液を調製した。 マルトースホスホリラーゼ0.2単位/ml トレハロースホスホリラーゼ0.158単位/ml りん酸二水素カリウム・クエン酸緩衝液40mM
(PH7.0) イミダゾール・塩酸緩衝液40mM(PH7.0) この混合液50mlにマルトース5gを加え37℃で
24時間撹拌した。その結果トレハロース2.95gが
生成し、未反応マルトースは1.0gであつた。次
いでこれを100℃にて10分間加熱し反応を停止さ
せ、遠心分離により沈殿を除去し、上清液を得
た。この上清液のトレハロース濃度は59mg/mlで
あつた。 次いで該上清液に水を加え100mlとし、充分水
洗したDowex1(OH-型、φ2×23 約72ml、ダウ
ケミカル社製)のカラムにかけ、次に約140mlの
水を流し、通過液と洗液を合わせた。この液に四
ホウ酸カリウムを加えその濃度が1mMとなる様
に調整した。この溶液をDowex1(ホウ酸型、φ
×33、約103ml、ダウケミカル社製)のカラムに
かけたトレハロースを吸着させた後、10mM四ホ
ウ酸カリウムで溶出した。溶出液は18mlづつ分画
した。トレハロースはNo.3〜72の溶出画分で得ら
れた。このNo.3〜72の画分を集めDowex50W
(H+型、φ2×33、約103ml、ダウケミカル社製)
のカラムにかけ、約200mlの水で洗浄し先の通過
液と合わせた。アンモニアでPHを中性にもどしロ
ータリーエバポレーターで濃縮した。メタノール
を加え蒸留を繰り返しホウ酸を除去した後、シロ
ツプ状になるまで減圧濃縮しエタノール48mlを加
えを加え沈殿を得た。溶接を50℃に加温するとと
もに少量の水を加え沈殿を溶解させた。その後4
℃で放置し、2日後生じた結晶を取し少量の冷
エタノールで洗浄して減圧下乾燥剤(シリカゲル
+五酸化リン)で1晩乾燥させ、柱状のトレハロ
ースの結晶約2.4gを得た。 かくして得られた結晶(以下とする)につい
てシグマ(Sigma)社製、市販高級試薬トレハロ
ース(以下とする)を対照に各種確認試験(1
〜5)を行つたところ、以下の通り本実施例で得
られた結晶は高純度のトレハロースであることが
確認された。 確認試験1 融点 :mp=133〜134℃ との混融試験でも同値を示した。 確認試験2 旋光度 :〔α〕21 D=+176.4゜(Cl水) :〔α〕21 D=+176.1゜ 確認試験3 IR とのIRを比較したところ2400〜2100cm-1
で若干相違が認められるが他は完全に一致した。
IR図を第1図に、またのIR図を第2図に示
す。 確認試験4 ガスクロマトグラフイー とのガスクロマトグラフイーを比較したと
ころ完全に一致した。の純度はに比べて118
%となつた。ガスコクロマトグラフイー分析図を
第3図に示す。図中1はを、2はを、3は
ととの50:50の混合物を示す。 第3図における測定条件は次の通りである。カ
ラム:金属カラム(1m) 固定相:5%SE−30/Chrom sorb カラム温度:160→250℃、5℃/minで昇温 入口温度及び検出温度:285℃ 流速:30ml/min 内部標準:1=シユクロース、2=トレハロース 確認試験5 純度 の結晶の還元力をソムジ−ネルソン
(Somgyi−Nelson)法で測定した結果、還元力
のないことが認められた。また0.1M酢酸緩衝液
(PH5.6)0.5mlにの水溶液4mlを加え、さらに
100μg/mlのトレハラーゼ水溶液0.1mlを加え37
℃で30分間反応させ生じたグレルコースをグルコ
ースオキシダーゼ溶液(グルコースオキシダーゼ
30mg及びパーオキシダーゼ3mgを50mMりん酸緩
衝液(PH7.0)90mlに溶解させ、ジアニジンジン
エタノール溶液1mlを加え、同緩衝液で100mlに
調整したもの)で定量しトレハロース量を求めた
ところの102%の純度を示した。 実施例 2 次の組成から成る混合液50mlにマルトース800
mgを加え、37℃で24時間撹伴したところ、トレハ
ロース475mg及びマルトース17.5mgが得られた。
これを実施例1と同様にてトレハロースの結晶
400mgを得た。 マルトースホスホリラーゼ 0.2単位/ml トレハロースホスホリラーゼ 0.1148単位/ml りん酸−クエン酸緩衝液 40mM(PH6.3) イミダゾール−塩酸溶液40mM(PH6.3)
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a novel method for producing trehalose. Trehalose, also called mycose, is a disaccharide widely distributed in natural products such as yeast, mold, and seaweed. Since it is extremely stable compared to other disaccharides such as sucrose, it is widely used as a sweetener, bulking agent, etc., and as an energy source. Conventionally, methods for obtaining this substance include extraction from the above-mentioned natural products or microorganisms belonging to the genus Arthrobacter [Agric.Biol.
Chem., 33 , No. 2, 190, 1969, Suzuki T.
Tanaka K & Kinoshita S] and microorganisms belonging to the genus Nocardia [Unexamined Japanese Patent Application Publication No. 1973-
154485], but these methods are difficult to mass produce or require operational, equipment, and energy costs to refine and obtain until they can be safely used as food. A large amount of investment is required, and currently no technology has been established for supplying trehalose at low cost and in large quantities. The present inventors have conducted extensive research with the aim of solving all the drawbacks of the conventional methods described above and providing a new method that can obtain trehalose in large quantities at low cost and with high yield. As a result, it has been found that trehalose can be easily produced in high yield when maltose, which is available at low cost and in large quantities, is used as a raw material and maltose phosphorylase and trehalose phosphorylase are combined to act on it. The present invention was completed based on this new knowledge. That is, the present invention relates to a method for producing trehalose, which is characterized in that trehalose is produced by treating maltose with maltose phosphorylase and trehalose phosphorylase. According to the method of the present invention, trehalose can be easily and efficiently obtained from maltose as a raw material in high yield by using the above two different enzymes in combination. The conversion rate (ie, yield) of maltose to trehalose by the method of the present invention is actually around 60%, which is completely unexpected from the known properties of each of the enzymes mentioned above. In the present invention, the enzyme treatment of raw maltose with a combination of maltose phosphorylase and trehalose phosphorylase is usually carried out in the presence of phosphoric acid in a suitable solvent. Each enzyme used here may be a known commercial product or one obtained by culturing microorganisms that produce the enzyme. In particular, examples of maltose phosphorylase include Neisseria meningitidis, (J.Biol.Chem.
199, 153-163 (1952) (and Lactobacillus
Enzymes produced by Lactobacillus brevis and the like are preferred. In addition, Euglena glatilis (Trehalose phosphorylase)
gracilis) (J.Biol.Chem., 247 , 3223-3228
(1972)) is preferred. The amounts of these enzymes used in combination are not particularly limited and are determined as appropriate. Maltose phosphorylase per mole of maltose, which is usually used as a raw material, is 0.1 unit or more,
Preferably about 350 units or more, and trehalose phosphorylase about 0.05 units or more, preferably about 200 units
It is better to consider it as more than a unit. The units expressing the amount of each enzyme are defined by the method described below. In addition, the phosphoric acid present in the enzyme treatment system is
In addition to orthophosphoric acid, various ordinary inorganic phosphoric acids and their salts such as sodium phosphate, potassium phosphate, sodium dihydrogen phosphate, potassium dihydrogen phosphate, etc. can be used. Among these, potassium dihydrogen phosphate is preferred. The phosphoric acid is also usually preferably used in the form of a phosphate buffer.
Therefore, the solvent constituting the enzyme treatment system is usually the water constituting the slow solution. Furthermore, various solvents that do not adversely affect the enzyme reaction, such as preferably imidazole-hydrochloric acid solution, can be added to the enzyme treatment system. The usage ratio (concentration) of the above phosphoric acid is not particularly limited, but there is usually about 0.1 mol or more, preferably about 0.5 to 1.5 mol of phosphoric acid (or its salt) per 1 mol of maltose as a raw material. It is best to define the amount (concentration) as The enzymatic reaction is usually completed in about 24 hours at a temperature of about 20 to 50°C, preferably about 37°C. The pH of the enzyme treatment reaction system is within a range in which none of the enzymes used is inactivated, usually preferably about 5 to 8, more preferably about 6 to 7. After the enzyme treatment reaction of the present invention is completed, the reaction solution is heated to inactivate the enzyme, and then centrifuged.
The precipitate is removed by any conventional means, and the resulting supernatant is purified by e.g.
1), manufactured by The Dow Chemical Company), CM-cellulose, etc., can be purified as a sugar solution by treatment with an anion type ion exchange resin such as CM-cellulose. type anion exchange resin, then 10
By elution with an aqueous solution of about mM potassium borate, trehalose is eluted first, and after the elution of trehalose is completed, unreacted maltose and by-product glucose are sequentially eluted. The trehalose fraction eluted in the above manner is passed through a cation-type ion exchange resin, the effluent is returned to near neutrality with ammonia, and after concentration, lower alcohols such as methanol and ethanol are added and distilled to remove boric acid. By removing , columnar trehalose crystals can be obtained. The method of the present invention also includes the immobilization of the above-mentioned two enzymes separately or in advance by mixing them in the above-mentioned appropriate proportions, and then immobilizing them according to known immobilization methods such as gel entrapment method, microcapsule method, etc. If each immobilized enzyme is immobilized separately, the resulting immobilized enzymes may be mixed in an appropriate ratio). According to this continuous method using an immobilized enzyme, there is very little contamination of impurities in the reaction system, and not only can even higher purity trehalose be easily obtained, but also the immobilized enzyme used can be used repeatedly, and the above-mentioned There is an advantage that trehalose can be produced more efficiently. The method using the above-mentioned immobilized enzyme is carried out by packing it into a suitable column and passing the raw material maltose dissolved in a phosphate buffer solution through this, and the passing liquid (enzyme-treated liquid) is It is purified using an ion exchange resin in the same way. Thus, according to the present invention, trehalose can be obtained at low cost, in large quantities, and in high yield. Examples will be given below to explain the present invention in more detail. Each enzyme used in each example was prepared by the following method. Preparation of maltose phosphorylase Lactobacillus brevis
brevis) IFO3345 cultured cells were crushed in a cell mill using glass beads (0.1 to 0.2 mm in diameter) and then centrifuged to collect 535 ml of supernatant (enzyme activity 2600 units). Next, add 2% to 515 ml of this supernatant.
Add 80ml of protamine sulfuric acid, stir at 12℃ for 30 minutes, centrifuge, and 580ml of supernatant (enzyme activity
2395 units) were recovered. Add 140 g of ammonium sulfate (40% saturation), stir at 2°C for 30 minutes, centrifuge to remove the precipitate, add 170 g of ammonium sulfate (80% saturation),
The mixture was allowed to stand at ℃ for 12 hours, and the resulting precipitate was obtained by centrifugation. Dissolve the precipitate in 100ml of 5mM citrate buffer (PH6.6) and incubate at 2°C with a large amount of the same buffer.
Dialysis was performed for 20 hours under cooling. DEAE was equilibrated with 5mM citrate buffer (PH6.6).
- passed through a cellulose column (4 x 27 cm in diameter);
It was adsorbed. 5mM citrate buffer (PH6.6)
After washing with 0-1M NaCl (citrate buffer,
Protein was eluted using a linear gradient of pH 6.6). Perform fractionation in 20 ml portions, collect active fractions, and add again to 5 mM citrate buffer (PH6.6).
20 hours of dialysis was performed on DEAE-
Column chromatography using cellulose was performed. Ammonium sulfate was added to the enzyme solution obtained in this operation to make it 80% saturated, and the mixture was left at 4°C overnight. The precipitate was collected by centrifugation and
It was dissolved in mM citrate buffer (PH6.6) to obtain 20 ml of crude enzyme preparation. Enzyme activity was 1638 units. The units in the above maltose phosphorylase were determined as follows. That is,
0.2 molar K2HPO4 -citrate buffer ( PH
Add 0.6ml of enzyme solution to 0.ml of 5.2) and incubate at 37°C.
Let stand for a minute to preheat. At this time, a control using water instead of the enzyme solution was prepared at the same time, and the same procedure was repeated. Next, add 0.2 ml of 0.2M maltose and react at 37°C for 10 minutes. The reaction is then stopped by immersing it in a boiling water bath. Next, the amount of glucose produced in this reaction solution is determined by the glucose oxidase method. The amount of enzyme that produced 1 μmol (180 μg) of glucose per minute under these conditions was defined as 1 unit. Preparation of trehalose phosphorylase Euglena glatilis
gracilis var.
Suspended in 600ml. 200ml of this was cooled in ice water and treated with ultrasound to crush the bacterial cells.
A supernatant was obtained by centrifugation at 8,000 rpm, and the precipitate was further washed, and the supernatant and washing solution were combined to obtain 1,610 ml of a crude enzyme extract. This solution was treated with protamine, and the precipitated enzyme was collected and resuspended in the same buffer as above to obtain 300 ml of a crude enzyme preparation. Its enzyme activity was 86 units. The units in the above trehalose phosphorylase were determined as follows. That is,
20ml of substrate solution (100mM imidazole-HCl buffer (PH7.0), 100mlM phosphate buffer (PH7.0),
Add 20μ of enzyme solution to 100mM trehalose and react at 37°C for 10 minutes, then add 0.5ml of Somogi reagent and incubate in a boiling water bath.
Heat for 15 minutes. Next, after cooling, add 0.5 ml of Nelson's reagent and leave at room temperature for 20 minutes. Next, add 4ml of water and compare the colors at 500nm.
Determine the amount of glucose produced in the reaction system. The amount of enzyme that produced 1 μmol of glucose per hour under these conditions was defined as 1 unit. Example 1 A liquid mixture having the following composition was prepared. Maltose phosphorylase 0.2 units/ml Trehalose phosphorylase 0.158 units/ml Potassium dihydrogen phosphate/citrate buffer 40mM
(PH7.0) Imidazole/hydrochloric acid buffer 40mM (PH7.0) Add 5g of maltose to 50ml of this mixture and heat at 37°C.
Stirred for 24 hours. As a result, 2.95 g of trehalose was produced, and 1.0 g of unreacted maltose. Next, this was heated at 100° C. for 10 minutes to stop the reaction, and the precipitate was removed by centrifugation to obtain a supernatant. The trehalose concentration of this supernatant was 59 mg/ml. Next, water was added to the supernatant liquid to make 100 ml, and the mixture was applied to a column of Dowex 1 (OH - type, φ2×23, approximately 72 ml, manufactured by Dow Chemical Company), which had been thoroughly washed with water. Next, approximately 140 ml of water was poured into the column to separate the passing liquid and washing liquid. combined. Potassium tetraborate was added to this solution and the concentration was adjusted to 1 mM. Add this solution to Dowex1 (boric acid type, φ
x33, approximately 103 ml, Dow Chemical Company) column to adsorb trehalose, and then eluted with 10 mM potassium tetraborate. The eluate was fractionated into 18 ml portions. Trehalose was obtained in elution fractions No. 3 to 72. Collect this No. 3 to 72 fractions and use Dowex50W.
(H + type, φ2×33, approx. 103ml, manufactured by Dow Chemical Company)
column, washed with about 200 ml of water, and combined with the previous passed-through solution. The pH was returned to neutral with ammonia, and the mixture was concentrated using a rotary evaporator. After adding methanol and repeating distillation to remove boric acid, the mixture was concentrated under reduced pressure until it became syrupy, and 48 ml of ethanol was added to obtain a precipitate. The weld was heated to 50°C and a small amount of water was added to dissolve the precipitate. then 4
After 2 days, the resulting crystals were collected, washed with a small amount of cold ethanol, and dried under reduced pressure with a drying agent (silica gel + phosphorus pentoxide) overnight to obtain about 2.4 g of columnar trehalose crystals. The thus obtained crystals (hereinafter referred to as below) were subjected to various confirmation tests (1
When steps 5) to 5) were carried out, it was confirmed that the crystals obtained in this example were highly pure trehalose as shown below. Confirmation Test 1 Melting point: mp = 133-134°C The same value was also shown in the mixed melting test. Confirmation test 2 Optical rotation: [α] 21 D = +176.4° (Cl water): [α] 21 D = +176.1° Confirmation test 3 Comparison of IR with IR shows 2400 to 2100 cm -1
There were slight differences in the results, but otherwise they were completely consistent.
The IR diagram is shown in Figure 1 and the IR diagram is shown in Figure 2. Confirmation Test 4 Gas Chromatography A comparison of the two gas chromatography results revealed complete agreement. The purity of is 118 compared to
%. A gas cochromatography analysis diagram is shown in Figure 3. In the figure, 1 indicates a 50:50 mixture of , 2 indicates a , and 3 indicates a 50:50 mixture of and . The measurement conditions in FIG. 3 are as follows. Column: Metal column (1m) Stationary phase: 5% SE-30/Chrom sorb Column temperature: 160→250℃, heating at 5℃/min Inlet temperature and detection temperature: 285℃ Flow rate: 30ml/min Internal standard: 1 = Sucrose, 2 = Trehalose Confirmation Test 5 The reducing power of the crystals of purity was measured by the Somgyi-Nelson method, and it was found that the crystals had no reducing power. Add 4 ml of an aqueous solution to 0.5 ml of 0.1M acetate buffer (PH5.6), and
Add 0.1 ml of 100 μg/ml trehalase aqueous solution 37
Glucose produced by reacting at ℃ for 30 minutes was mixed with glucose oxidase solution (glucose oxidase
102 % purity. Example 2 Add 800 g of maltose to 50 ml of a mixture consisting of the following composition:
When 475 mg of trehalose and 17.5 mg of maltose were obtained, 475 mg of trehalose and 17.5 mg of maltose were obtained.
Crystals of trehalose were prepared in the same manner as in Example 1.
Got 400mg. Maltose phosphorylase 0.2 units/ml Trehalose phosphorylase 0.1148 units/ml Phosphate-citrate buffer 40mM (PH6.3) Imidazole-hydrochloric acid solution 40mM (PH6.3)

【図面の簡単な説明】[Brief explanation of drawings]

第1図は本発明で得られるトレハロースの赤外
線吸収スペクトル分析図、第2図は市販トレハロ
ースの同分析図及び第3図は上記各トレハロース
のガスクロマトグラフイー分析図である。
FIG. 1 is an infrared absorption spectrum analysis diagram of trehalose obtained by the present invention, FIG. 2 is the same analysis diagram of commercially available trehalose, and FIG. 3 is a gas chromatography analysis diagram of each of the above-mentioned trehaloses.

Claims (1)

【特許請求の範囲】[Claims] 1 マルトースをマルトースホスホリラーゼ及び
トレハロースホスホリラーゼで処理してトレハロ
ースを製造することを特徴とするトレハロースの
製造方法。
1. A method for producing trehalose, which comprises producing trehalose by treating maltose with maltose phosphorylase and trehalose phosphorylase.
JP9812582A 1982-06-07 1982-06-07 Preparation of trehalose Granted JPS58216695A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP9812582A JPS58216695A (en) 1982-06-07 1982-06-07 Preparation of trehalose

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9812582A JPS58216695A (en) 1982-06-07 1982-06-07 Preparation of trehalose

Publications (2)

Publication Number Publication Date
JPS58216695A JPS58216695A (en) 1983-12-16
JPS6360998B2 true JPS6360998B2 (en) 1988-11-28

Family

ID=14211554

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9812582A Granted JPS58216695A (en) 1982-06-07 1982-06-07 Preparation of trehalose

Country Status (1)

Country Link
JP (1) JPS58216695A (en)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995034570A1 (en) * 1994-06-10 1995-12-21 Kyowa Hakko Kogyo Co., Ltd. Process for producing disaccharides and novel saccharides
JPS63240758A (en) * 1987-03-30 1988-10-06 Natl Food Res Inst Novel food material
GB8715238D0 (en) * 1987-06-29 1987-08-05 Quadrant Bioresources Ltd Food process
CA2016363A1 (en) * 1989-06-05 1990-12-05 Kazuho Matsuura Method of producing trehalose
JPH05211882A (en) * 1991-12-11 1993-08-24 Ajinomoto Co Inc Trehalose manufacturing method
US5677442A (en) * 1992-12-28 1997-10-14 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Method of crystallizing trehalose without using organic solvent
ATE182359T1 (en) * 1992-12-28 1999-08-15 Hayashibara Biochem Lab NON-REDUCING SACCHARIDE-FORMING ENZYME, AND PRODUCTION AND USES THEREOF
JP3633648B2 (en) * 1993-07-20 2005-03-30 株式会社林原生物化学研究所 Maltose / trehalose converting enzyme, its production method and use
US5565341A (en) * 1993-08-13 1996-10-15 Kureha Chemical Industry Co., Ltd. Process for producing trehalose
US5871993A (en) * 1994-02-23 1999-02-16 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo DNA encoding enzyme, recombinant DNA and enzyme, transformant, and their preparations and uses
KR100374449B1 (en) * 1994-03-07 2003-09-06 가부시끼가이샤 하야시바라 세이부쓰 가가꾸 겐꾸조 DNA encoding enzymes, recombinant DNA (DNA) and enzymes, transformants and methods of making them
JPH07327691A (en) * 1994-04-15 1995-12-19 Kureha Chem Ind Co Ltd Production of trehalose
JP3557277B2 (en) * 1994-06-25 2004-08-25 株式会社林原生物化学研究所 Thermostable trehalose releasing enzyme, its production method and use
US5908767A (en) * 1994-06-02 1999-06-01 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Non-reducing saccharide and its production and use
JP3793590B2 (en) * 1994-06-27 2006-07-05 株式会社林原生物化学研究所 Non-reducing saccharides, production method and use thereof
JP3650632B2 (en) 1994-06-16 2005-05-25 株式会社林原生物化学研究所 Recombinant enzyme that converts maltose to trehalose
US5714368A (en) * 1994-06-24 1998-02-03 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Thermostable non-reducing saccharide-forming enzyme its production and uses
IL114030A (en) * 1994-06-27 2000-08-13 Hayashibara Biochem Lab Saccharide composition with a lesser reducibility its preparation and compositions containing it
EP0693558B1 (en) 1994-07-19 2002-12-04 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Trehalose and its production and use
JP3557289B2 (en) * 1994-07-21 2004-08-25 株式会社林原生物化学研究所 Recombinant thermostable enzyme that releases trehalose from non-reducing carbohydrates
JP3557288B2 (en) * 1994-07-21 2004-08-25 株式会社林原生物化学研究所 Recombinant thermostable enzyme that produces non-reducing carbohydrates with terminal trehalose structure from reducing starch sugars
US6586006B2 (en) 1994-08-04 2003-07-01 Elan Drug Delivery Limited Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
DE69532106T2 (en) * 1994-09-16 2004-07-22 Nihon Shokuhin Kako Co., Ltd. Maltose Phospharylase, Trehalose Phophorylase, Plesiomonas Strain, and Preparation of Trehalose
JPH10508744A (en) 1994-09-22 1998-09-02 クオドラント ホールディングス ケンブリッジ リミテッド Compositions for hydration and nutritional use during athletics and methods of making the same
JP3810457B2 (en) * 1994-10-01 2006-08-16 株式会社林原生物化学研究所 Recombinant thermostable enzyme that converts maltose to trehalose
JP3084609B2 (en) * 1995-04-12 2000-09-04 株式会社林原生物化学研究所 Trehalose-containing syrup
US6964771B1 (en) 1995-06-07 2005-11-15 Elan Drug Delivery Limited Method for stably incorporating substances within dry, foamed glass matrices
US5958455A (en) * 1996-02-09 1999-09-28 Quadrant Holdings Cambridge Ltd Oral solid dosage forms, methods of making same and compositions thereof
US5762961A (en) * 1996-02-09 1998-06-09 Quadrant Holdings Cambridge Ltd. Rapidly soluble oral solid dosage forms, methods of making same, and compositions thereof
US6632648B1 (en) 1996-05-14 2003-10-14 Elan Drug Delivery Limited Methods of terminal sterilization of fibrinogen
US6468782B1 (en) 1996-12-05 2002-10-22 Quadrant Healthcare (Uk) Limited Methods of preserving prokaryotic cells and compositions obtained thereby
JP4034846B2 (en) * 1996-12-10 2008-01-16 株式会社林原生物化学研究所 Crystalline powdered sugar, production method and use thereof
EP0868916A3 (en) 1997-03-04 2004-09-15 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Reduction inhibitory agent for active-oxygen eliminating activity
JP4034862B2 (en) 1997-06-02 2008-01-16 株式会社林原生物化学研究所 Method for improving aftertaste of sucrose and its use
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
JPH11116588A (en) 1997-10-16 1999-04-27 Hayashibara Biochem Lab Inc Production of trehalose and sugar alcohol
JP3944323B2 (en) 1998-04-22 2007-07-11 株式会社林原生物化学研究所 Non-fried cooking method and its use
JP4221078B2 (en) 1998-07-09 2009-02-12 株式会社林原生物化学研究所 Trehalose dihydrate crystal, its production method and use
TWI283695B (en) 1999-10-21 2007-07-11 Hayashibara Biochem Lab Thermoplastic shaped-body of trehalose, process and uses thereof
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
TWI304424B (en) 2001-04-26 2008-12-21 Hayashibara Biochem Lab
AU2002307701C1 (en) * 2001-05-28 2008-04-03 Ezaki Glico Co., Ltd. Production method and preparation method of glucans
JP3759018B2 (en) * 2001-10-18 2006-03-22 株式会社林原生物化学研究所 Plum meat sheet using trehalose
PT1458360E (en) 2001-12-19 2011-07-13 Novartis Ag Pulmonary delivery of aminoglycosides

Also Published As

Publication number Publication date
JPS58216695A (en) 1983-12-16

Similar Documents

Publication Publication Date Title
JPS6360998B2 (en)
Uchiyama et al. Purification and properties of Arthrobacter ureafaciens inulase II
Kaplan et al. [129] Preparation of DPN derivatives and analogs
Ghalambor et al. The biosynthesis of cell wall lipopolysaccharide in Escherichia coli: IV. Purification and properties of cytidine monophosphate 3-deoxy-d-manno-octulosonate synthetase
FI56537C (en) FOERFARANDE FOER OMVANDLANDE AV GLUCOSIS TILL FRUKTOS MED TILLHJAELP AV GLUCOSISOMERAS
Liao et al. Purification of guanosine 5′-diphosphate d-mannose oxidoreductase from Phaseolus vulgaris
EP0096547B1 (en) Process for preparing uridine diphosphate-n-acetylgalactosamine
Cuatrecasas et al. Mammalian galactose dehydrogenase: I. Identification and purification in rat liver
Haynie et al. Enzyme-catalyzed organic synthesis of sucrose and trehalose with in situ regeneration of UDP-glucose
Ciliv Human erythrocyte acetylcholinesterase purification, properties and kinetic behavior
JP2769992B2 (en) Glucosamine-6-phosphate deaminase
JPH0329241B2 (en)
NOMURA et al. Studies on 3'-Nucleotidase-nuclease from Potato Tubers I. Purification and Some Properties of the Enzyme
CN114958941A (en) Method for co-production of D-galactose and gluconic acid or gluconate through enzyme catalysis of lactose
Das et al. Immobilization of cane amylase and acid phosphatase on tricalcium phosphate (TCP) gel
Allen et al. Studies on the structure and mechanism of action of the malate-lactate transhydrogenase
Horitsu et al. Pentose metabolism in Candida utilis: Part IV. NADP specific polyol dehydrogenase
US4463093A (en) Process for isomerizing L-glucose to L-fructose
SU1571047A1 (en) Method of obtaining water-soluble oligosaccharides
JPS6342698A (en) Enzymatic synthesis of trisaccharides containing n-acetylneuraminic acid
SUGIMOTO et al. Purification and properties of beef liver D-glycerate dehydrogenase
JPH06253878A (en) Method for producing lacto-N-biose I and 2-acetamido-2-deoxy-3-O-β-D-galactopyranosyl-D-galactopyranose
CN119144635B (en) Method and engineering bacteria for preparing (β, S) configuration boson by enzyme catalysis
JPH04200386A (en) Beta-fructofuranosidase and production thereof
JPS6120268B2 (en)